[gold stone subdrug: oseltamivir phosphate capsule accepted notice of application for drug registration] Financial Associated Press, June 14, Jinshi subdrug announcement, the company is working on the product oseltamivir phosphate capsule to obtain a notice of drug registration acceptance. The indication of the drug is the treatment of influenza An and B in adults and children aged 1 year and above, and the prevention of influenza An and B in adults and adolescents aged 13 and over.